AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)
$20.09 -0.44 (-2.1432%)
Analysed AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) News Sources
The 5 Most Interesting Analyst Questions From Amphastar Pharmaceuticals’s Q1 Earnings Call
17-05-2026
yahoo.com
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Lower Today
18-05-2026
yahoo.com
Why Wells Fargo Lowered Amphastar Pharmaceuticals, Inc. (AMPH) Price Target to $19
20-05-2026
yahoo.com
3 Stocks Under $50 with Open Questions
26-05-2026
yahoo.com
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference
27-05-2026
yahoo.com
Amphastar Pharmaceuticals, Inc. (AMPH) Price Target Cut to $21 At Piper Sandler Amid Pipeline Uncertainty
02-06-2026
yahoo.com
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag
04-06-2026
marketbeat.com
How The Investment Story For Amphastar Pharmaceuticals (AMPH) Is Evolving Without New Valuation Shifts
09-06-2026
yahoo.com
Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth
10-06-2026
marketbeat.com
1 Healthcare Stock to Consider Right Now and 2 We Brush Off
12-06-2026
yahoo.com
What is the current price of AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)?
The current price of AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) is $20.09.
AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) absolute price change since previous trading day?
The absolute price change of AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) since the previous trading day is $-0.44.
AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) percentage price change since previous trading day?
The percentage price change of AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) since the previous trading day is -2.1432%.
What is the most recent average sentiment score for AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)?
The most recent average sentiment score for AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) is 58 out of 100.
What is the most recent average sentiment for AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)?
The most recent sentiment for AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) is .
SEC-8K** Filing Available For AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.